Clinical trials
Diabetes (Insulin-requiring, Type 1 or Type 2) clinical trials
Below are recruiting diabetes (insulin-requiring, type 1 or type 2) clinical trials, each written for real people, not researchers. We’re tracking 2,195 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04579900Recruiting
Study how gut microbes affect type 2 diabetes risk
This study looks at how differences in gut microbes may relate to risk of developing type 2 diabetes. It may help researchers understand who is more likely to develop diabetes, and why.
Québec, QuebecAges 18–60 - NCT04583800Recruiting
Tracking heart failure risk and memory change in diabetes
This study follows adults with type 2 diabetes to see who may develop heart problems and who may have memory or thinking changes over time. It may help doctors better predict risk and plan earlier support.
LilleAges 18 years+ - NCT04831385Recruiting
CBT-I sleep therapy to improve blood sugar in older adults
This study tests whether a structured therapy for insomnia (CBT-I) can help improve blood sugar control in older adults with type 2 diabetes. It targets people who have both high blood sugar levels and troublesome insomnia, aiming to see if better sleep improves glycemic measurements.
Hong KongAges 60 years+ - NCT04874012RecruitingPhase 2
Taurine supplement study for blood sugar, fats, and inflammation
This Phase 2 study tests whether taking taurine affects blood sugar control, cholesterol/fats, and inflammation in people with type 2 diabetes. It may help by improving these lab markers, which are linked to long-term health risks.
Porto Alegre, Rio Grande do SulAges 30–80 - NCT04889053Recruiting
CT heart scan study in adults with type 2 diabetes
This trial uses a low-dose CT scan of the heart’s arteries to measure coronary artery calcification in people with type 2 diabetes. It aims to better understand heart calcium buildup and may help improve risk assessment for people with diabetes.
HengyangAges 18 years+ - NCT04917471Recruiting
Testing nitrate to improve red blood cell function in type 2 diabetes
This study looks at whether taking nitrate can improve how red blood cells work in people with type 2 diabetes. You may be asked to follow a specific plan and avoid certain foods or medicines that could affect the results.
StockholmAges 18 years+ - NCT04932928Recruiting
Using a glucose sensor to improve type 2 diabetes
This study checks whether patient-guided lifestyle changes, supported by a continuous glucose monitor (a sensor), can improve blood sugar control in adults with type 2 diabetes. It may help you and your care team see how food, activity, and habits affect your readings.
SeoulAges 19–80 - NCT04941794Recruiting
Test heart-related blood markers in people with type 2 diabetes
This study looks at blood tests (called biomarkers) to see if they can help predict chronic heart failure risk. It focuses on adults with type 2 diabetes over age 50 who do not already have certain heart conditions.
HjørringAges 50 years+ - NCT04993482Recruiting
Tracks daily movement habits in adults with type 2 diabetes
This study looks at your usual 24-hour movement pattern (like being active, sitting, and sleeping). It may help researchers better understand daily behavior patterns in people with type 2 diabetes.
GhentAges 18–100 - NCT05138432Recruiting
More fresh fruit and vegetables for kids with type 2 diabetes
This study tests whether giving families extra fresh fruits and vegetables helps children manage type 2 diabetes. It’s delivered through a “prescription” program and may support healthier eating habits.
San Diego, CaliforniaAges Up to 18 years - NCT05139784Recruiting
Study of immune changes in people with type 1 diabetes and other diabetes
This study looks at immune (defense system) and blood-sugar changes in people with type 1 diabetes, and in some other diabetes or autoimmune hormone conditions. It includes people who will have a specific abdominal surgery so doctors can safely study lymph node tissue.
Bobigny, Île-de-France RegionAges 1 year+ - NCT05153070RecruitingPhase 2
Cyclosporine then low-dose immune therapy for new type 1 diabetes
This Phase 2 study tests whether starting with cyclosporine and then giving low-dose IL-2 can better protect the body’s insulin-producing function after type 1 diabetes is diagnosed. It’s meant for people diagnosed very recently who have specific diabetes-related immune markers.
ParisAges 16–45 - NCT05188027Recruiting
Exercise types for postmenopausal women with type 1 diabetes
This study compares aerobic exercise (like brisk walking) versus resistance exercise (like strength training) to see which works better for women with type 1 diabetes after menopause. It may help you learn which exercise approach is safest and most helpful for blood sugar and health.
Edmonton, AlbertaAges 45–75 - NCT05203640Recruiting
Strength exercise study for post-menopausal type 1 diabetes
This study checks whether a resistance (strength) exercise program changes blood sugar levels in post-menopausal women with type 1 diabetes. You may be asked to do supervised lab-based exercise sessions near the University of Alberta.
Edmonton, AlbertaAges 45–75 - NCT05208164Recruiting
Mindfulness program for Black adults with type 2 diabetes
This study tests whether a mindfulness class, delivered by text messages and online or in-person sessions, can help adults with type 2 diabetes. It is designed specifically for African American/Black participants in the Chicago area.
Chicago, IllinoisAges 21–75 - NCT05268237RecruitingPhase 1/Phase 2
Testing a diabetes pill under the tongue for type 2 diabetes
This early-phase study tests the safety and side effects of liraglutide taken under the tongue, and looks for early signs it improves blood sugar in people with type 2 diabetes. It may help people who want an alternative way to get this medication, but the main goal is to see how safe and tolerable it is.
Hong KongAges 18–65 - NCT05269589Recruiting
Home heat therapy for people with type 2 diabetes
This trial tests whether using heat therapy at home can improve health in adults with type 2 diabetes. It may help people who already have stable diabetes treatment, but it is not for everyone, especially if certain heart, nerve, or vision problems are present.
Montreal, QuebecAges 45–75 - NCT05307731RecruitingPhase 4
Fingolimod for adults with type 2 diabetes
This trial studies whether fingolimod can improve diabetes in adults with type 2 diabetes who are not yet on many medications. It will mainly check whether the drug is safe and whether it can help control blood sugar over time.
ShenyangAges 18–70 - NCT05317455RecruitingEarly Phase 1
Studying brain sugar changes in adults with risky low blood sugar
This early-stage study looks at how the brain uses sugar in people with type 1 diabetes who have had severe or hard-to-notice low blood sugar. It may help researchers understand the brain effects of low blood sugar and guide safer care.
New Haven, ConnecticutAges 18–55 - NCT05322213RecruitingPhase 1
THC study for blood sugar control in type 2 diabetes
This early-phase study tests how THC (the main cannabis ingredient) affects blood sugar levels in people with type 2 diabetes. It may help researchers understand whether THC changes glucose control and what risks come with it.
La Jolla, CaliforniaAges 21–70 - NCT05325710Recruiting
Personalized follow-up to help prevent type 2 diabetes
This study tests whether a more personalized check-in plan can help people lower their risk of developing type 2 diabetes. You may be able to get closer guidance focused on your risk level.
Biarritz, AquitaineAges 18–75 - NCT05345327RecruitingPhase 3
First diabetes pill to protect kidneys
This Phase 3 trial tests whether starting a diabetes medicine called dapagliflozin can better slow kidney damage than starting metformin in adults with type 2 diabetes. It may help preserve kidney function over time and reduce future kidney decline.
Sydney, New South WalesAges 18 years+ - NCT05359796Recruiting
Study of long-term type 1 diabetes symptoms and characteristics
This study looks at what day-to-day health and medical features are like in people who have had type 1 diabetes for many years. It may help researchers better understand long-term needs in type 1 diabetes and guide future care.
Changsha, HunanAges Any age - NCT05363761RecruitingPhase 1
Artery procedure to treat type 2 diabetes and related problems
This Phase 1 study tests a new artery “ablation” procedure for people with type 2 diabetes, aiming to improve diabetes and related conditions like high blood pressure. It will also check whether the procedure is safe and works well enough to study further.
Panama CityAges 21–65
Hear when a new Diabetes (Insulin-requiring, Type 1 or Type 2) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes (insulin-requiring, type 1 or type 2)?
- Yes. Clin2 currently lists 2,195 recruiting diabetes (insulin-requiring, type 1 or type 2) studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes (insulin-requiring, type 1 or type 2) trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes (insulin-requiring, type 1 or type 2) trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.